Literature DB >> 808758

Focal seizures and aminophylline.

P R Yarnell, N S Chu.   

Abstract

Intravenous aminophylline therapy for acute exacerbation of chronic obstructive pulmonary disease may trigger prolonged and difficult to control focal motor seizures with generalization. This can occur in previously neurologically asymptomatic patients and be associated with a poor outcome. Most patients exhibited periodic lateralized epileptiform discharges or had autopsy-proved focal central nervous system lesions, or both. If focal and generalized seizures develop during aminophylline therapy, drug toxicity should be suspect as announcing a focal central lesion. Careful individual monitoring of aminophylline dose and administration rate is essential.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808758     DOI: 10.1212/wnl.25.9.819

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Seizures associated with regadenoson: a case series.

Authors:  Robert Lee Page; Patrice Spurck; Jacquelyn L Bainbridge; Julie Michalek; Robert A Quaife
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

Review 2.  Adverse reactions and interactions with theophylline.

Authors:  M H Skinner
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

3.  Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  K Takagi; T Kuzuya; T Horiuchi; M Nadai; R Apichartpichean; Y Ogura; T Hasegawa
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  T Hasegawa; K Takagi; T Kuzuya; M Nadai; R Apichartpichean; I Muraoka
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.

Authors:  T Hasegawa; K Takagi; M Nadai; Y Ogura; T Nabeshima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.

Authors:  R A Upton; L Sansom; T W Guentert; J R Powell; J F Thiercelin; V P Shah; P E Coates; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

7.  Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults.

Authors:  R A Upton; J F Thiercelin; T W Guentert; S M Wallace; J R Powell; L Sansom; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

8.  Influence of aminophylline on the anticonvulsive action of gabapentin in the mouse maximal electroshock seizure threshold model.

Authors:  J J Luszczki; K Jankiewicz; M Jankiewicz; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  2007-08-24       Impact factor: 3.575

Review 9.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

10.  Theophylline-induced seizures: clinical and pathophysiologic aspects.

Authors:  T Nakada; I L Kwee; A M Lerner; M P Remler
Journal:  West J Med       Date:  1983-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.